Navigation Links
IPC The Hospitalist Company, Inc. to Present at Deutsche Bank 2009 Small and Mid Cap Conference
Date:2/2/2009

NORTH HOLLYWOOD, Calif., Feb. 2 /PRNewswire-FirstCall/ -- IPC The Hospitalist Company, Inc. (Nasdaq: IPCM), a leading national physician group practice company, announced today that management is scheduled to present at the Deutsche Bank 2009 Small and Mid Cap Conference held in Naples, FL.

                   Deutsche Bank 2009 Small and Mid Cap Conference
                   Speaker:         Adam Singer, M.D., Chairman and CEO
                   Date:            Thursday, February 12, 2009
                   Time:            12:00 PM Eastern
                   Place:           Ritz-Carlton Resort, Naples, FL

A live Web cast of the presentation will also be available by visiting the investor relations section of the Company's Web site. A replay of the presentation will be available for 30 days.

About IPC The Hospitalist Company

IPC The Hospitalist Company, Inc. (Nasdaq: IPCM) is a leading national physician group practice company focused on the delivery of hospitalist medicine services. IPC's physicians and affiliated providers manage the care of hospitalized patients in coordination with primary care physicians and specialists. The Company provides its hospitalists with the comprehensive training, information technology, and management support systems necessary to improve the quality and reduce the cost of inpatient care in the facilities it serves. For more information, visit the IPC website at www.hospitalist.com.

    Contacts:
    Devra Shapiro                          Stephanie Carrington/Amy Glynn
    IPC The Hospitalist Company, Inc.      The Ruth Group
    (818) 766-3502                         646-536-70
'/>"/>
SOURCE IPC The Hospitalist Company, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. IPC The Hospitalist Company, Inc. to Present at UBS 2009 Global Healthcare Services Conference
2. IPC The Hospitalist Company, Inc. Reaffirms Guidance for 2008
3. CMS, Inc., an Elekta Company, Announces Commercial Availability of Focal4D(TM)
4. Kowa Company, Ltd. Acquires ProEthic Pharmaceuticals, Inc.
5. Arena Pharmaceuticals to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference
6. Inverness Medical Innovations to Present at 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on June 12, 2008
7. Idenix Pharmaceuticals to Present at the Seventh Annual Needham and Company, LLC Biotechnology and Medical Technology Conference
8. Takedas Antibody Therapeutics Research Company, Takeda San Francisco, Inc. Appoints Mary Haak-Frendscho, Ph.D. as President and CSO
9. Amnis and Gene Company, Ltd. Announce Agreement to Market ImageStream Technology in China
10. Pathology Consultants, Inc. Selects PSA, LLC, a MED3OOO Company, as Their Business Partner
11. InnovationRx, a Prescription Adherence Solutions Company, and InforMedix Partner to Market and Sell End-to-End Medication Adherence Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015   PureTech , a science and ... disruptive products and technologies in the healthcare sector, announced ... CEO and Member of the Board of Directors of ... "It,s has been a pleasure to know Chris for ... will be working together more closely now," said Dr. ...
(Date:2/26/2015)... 26, 2015 On behalf of biotech client ... Wilentz, Goldman & Spitzer, P.A. (Wilentz) secured a ... Genewiz Inc. in excess of $10 million. The jury ... secrets, and that it improperly hired one or more ... motions for judgment notwithstanding the verdict, a new trial, ...
(Date:2/26/2015)... , Feb. 26, 2015 /PRNewswire/ - SQI Diagnostics ... a life sciences company that develops and commercializes proprietary ... its financial and operational results for the fiscal first ... press release are in Canadian dollars (CAD), unless otherwise ... continued to win new business from our existing customers ...
(Date:2/26/2015)... Feb. 26, 2015   Regulus Therapeutics Inc . ... the discovery and development of innovative medicines targeting microRNAs, ... President and Chief Executive Officer of Regulus, will present ... th Annual Healthcare Conference on Wednesday, March 4, ... held at the Boston Marriott Copley Place.  ...
Breaking Biology Technology:Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3
... Named 2007 Medical Products Industry Leader, DEERFIELD, Ill., ... announced today that it has been named 2007,Medical Products ... World) and the Dow Jones Sustainability North America Index,(DJSI ... the,company has been listed in the DJSI and the ...
... 12 ABR-Affinity,BioReagents, a leading global antibody ... through distribution agreements with,Genesis Biotech and Good ... with Antibody Shop,A/S and Ab Frontier, ABR-Affinity ... Biotech, a manufacturer of antibodies,focusing on gene ...
... Palatin,Technologies, Inc. (Amex: PTN ) stated ... 2007 by Competitive Technologies, Inc. (Amex: CTT ... a license agreement was,false and misleading. The ... Technologies,Terminates License Agreement with Palatin Technologies." However, the,Notice ...
Cached Biology Technology:Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year 2ABR-Affinity BioReagents Announces Agreements for U.S. Distribution of Research Antibodies 2Palatin Technologies Refutes Competitive Technologies Contention of Material Breach 2
(Date:2/10/2015)... 2015  Alere Inc. (NYSE: ALR), a global ... for the quarter ended December 31, 2014. ... of Alere said, "We made substantial progress in ... global leader in rapid diagnostics and delivering against ... divestiture in early January enabled us to substantially ...
(Date:2/5/2015)... , Feb. 5, 2015  Marken is starting its ... and has launched a new marketing campaign to solidify ... (CLO).  The new campaign focuses on First ... and shipments. The first headline in the ... Marken,s priorities with its client,s priorities. Marken recognizes the ...
(Date:2/5/2015)... Jan. 27, 2015   Marvin Test ... deployed, innovative test solutions for military, aerospace, ... of its TS-323 GENASYS Test Platform ... (LMSSC). GENASYS is a high-performance PXI-based system ... applications that require performance functional testing. GENASYS ...
Breaking Biology News(10 mins):Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34Alere Inc. Announces Fourth Quarter 2014 Results 35Alere Inc. Announces Fourth Quarter 2014 Results 36
... Alexandria, VA The American Geological Institute (AGI), ... the release of "Critical Needs for the Twenty ... concise document suggests policy directions for the next ... States Congress. The document identifies seven national issues ...
... Coalition today gave Senator Charles Schumer its "Champion of ... advocacy for basic research funding. With New York,s wealth ... basic research in maintaining America,s competitiveness in the global ... State Assemblyman, a U.S. Congressman and now a U.S. ...
... Earlier today, some 300 feet below the Earth,s surface, ... from Switzerland into France and back again, scientists at ... for Nuclear Research (CERN) in Geneva fired the first ... history-making science. A contingent of more than 40 ...
Cached Biology News:UC Santa Barbara has key role in Large Hadron Collider project 2UC Santa Barbara has key role in Large Hadron Collider project 3UC Santa Barbara has key role in Large Hadron Collider project 4
... based acquision and analysis software ... type applications. Contains powerful stimulus ... analysis functions including automated waveform ... Also includes many electrophysiology specific ...
Peptide-affinity Purified Polyclonal Antibody to ICEBERG Peptide with sequence EEDPQLASKMGLH, from C Terminus of the protein sequence according to NP_067546...
EDG-6 Lysate Source: Cell Lysate Application: Western Blotting Control Form: IgG...
3T3 cells (RSV-transformed) Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
Biology Products: